These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2939135)

  • 1. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C.
    Schick B; Austen KF
    J Immunol; 1986 May; 136(10):3812-8. PubMed ID: 2939135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of a rat serosal mast cell membrane component during degranulation mediated by chymase, a secretory granule protease.
    Schick B
    Immunology; 1990 Mar; 69(3):423-8. PubMed ID: 2312165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of chymase-mediated rat serosal mast cell degranulation by trypsin or diisopropyl fluorophosphate.
    Schick B; Austen KF
    Immunology; 1989 Mar; 66(3):434-8. PubMed ID: 2522909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease.
    Schick B; Austen KF; Schwartz LB
    J Immunol; 1984 May; 132(5):2571-7. PubMed ID: 6425408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease.
    Schick B; Austen KF
    Immunology; 1985 Nov; 56(3):513-22. PubMed ID: 3935569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
    Goldstein SM; Leong J; Schwartz LB; Cooke D
    J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release.
    Kido H; Fukusen N; Katunuma N
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():95-100. PubMed ID: 2462436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.
    Doggrell SA; Wanstall JC
    Cardiovasc Res; 2004 Mar; 61(4):653-62. PubMed ID: 14985062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
    Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
    J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S; Gaça MD; McEuen AR; Walls AF
    J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell chymase. A potent secretagogue for airway gland serous cells.
    Sommerhoff CP; Caughey GH; Finkbeiner WE; Lazarus SC; Basbaum CB; Nadel JA
    J Immunol; 1989 Apr; 142(7):2450-6. PubMed ID: 2494259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Ca2+ flux is a critical determinant of the Ca2+ dependence of mast cell degranulation.
    Suzuki Y; Yoshimaru T; Inoue T; Ra C
    J Leukoc Biol; 2006 Mar; 79(3):508-18. PubMed ID: 16365155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases.
    Eklund KK; Humphries DE; Xia Z; Ghildyal N; Friend DS; Gross V; Stevens RL
    J Immunol; 1997 May; 158(9):4373-80. PubMed ID: 9127001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE receptor-mediated phosphatidylinositol hydrolysis and exocytosis from rat basophilic leukemia cells are independent of extracellular Ca2+ in a hypotonic buffer containing a high concentration of K+.
    Hohman RJ; Hultsch T; Talbot E
    J Immunol; 1990 Dec; 145(11):3876-82. PubMed ID: 2147206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.